Stay updated on Pembrolizumab in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab in mCRPC Clinical Trial page
- ChecktodayChange DetectedThe page shows a site revision: 'Revision: v3.4.2' is listed, with a prior entry for v3.4.1 and a legacy government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check7 days agoChange DetectedAdded a site-wide funding notice and updated the page to revision v3.4.1, removing v3.4.0.SummaryDifference0.4%

- Check14 days agoChange DetectedAdded a glossary toggle and a 'Last Update Submitted that Met QC Criteria' label; capitalization adjusted for 'No FEAR Act Data' and the site revision updated to v3.4.0.SummaryDifference0.2%

- Check28 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded a dedicated Locations section with California (San Francisco, CA) listed as a study site. The previous California Locations header was removed and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check72 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.